Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk
Lee DS, Evans JC, Robins SJ, et al. • Arterioscler Thromb Vasc Biol
Key Finding
GGT independently predicts metabolic syndrome and CVD risk
Original title: “Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk”
Plain English Summary
Using Framingham Offspring Study data, this research demonstrated that GGT predicts metabolic syndrome, cardiovascular events, and mortality independently of traditional risk factors. Higher GGT within "normal" ranges was associated with increased risk, suggesting current reference ranges may be too permissive for identifying cardiovascular risk.
In-Depth Analysis
Background
Dr. Dong Soon Lee and colleagues analyzed Framingham Offspring Study data, publishing in Arteriosclerosis, Thrombosis, and Vascular Biology (PMID: 17095717, DOI: 10.1161/01.ATV.0000251993.20372.40).
Study Design
Population: 3,451 Framingham Offspring Study participants Follow-up: Up to 19 years Outcomes: Incident metabolic syndrome, CVD events, all-cause mortality Analysis: Cox regression with adjustment for traditional risk factors
Key Findings
GGT quartiles and incident metabolic syndrome (Q4 vs Q1):
- •Men: HR 3.2 (95% CI: 2.1-4.9)
- •Women: HR 3.4 (95% CI: 2.1-5.5)
GGT and cardiovascular events:
| GGT Quartile | CVD Events HR | Mortality HR |
|---|---|---|
| Q1 | 1.0 (reference) | 1.0 (reference) |
| Q2 | 1.18 | 1.09 |
| Q3 | 1.32 | 1.28 |
| Q4 | 1.68 (1.22-2.33) | 1.56 (1.18-2.06) |
Critical finding: Elevated GGT within the "normal" laboratory range still predicted cardiovascular events.
Mechanistic Insights
The authors proposed GGT serves as an integrated marker of:
- •Hepatic steatosis (liver fat)
- •Oxidative stress (glutathione demand)
- •Insulin resistance (upstream driver)
- •Subclinical inflammation
These interconnected pathways explain why GGT predicts metabolic syndrome development.
Clinical Implications
GGT screening provides additive value for metabolic and cardiovascular risk assessment. Upper-normal GGT warrants metabolic evaluation even when liver function appears normal.
Metabolic Health Perspective
The Framingham data validate GGT as an early warning marker for metabolic dysfunction. In metabolic optimization, GGT serves as a monitoring parameter—improvements in diet and lifestyle lower GGT alongside other risk markers.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
Conventional clinical guidelines used by most doctors
Not directly relevant to this paradigm
Research Consensus
Current scientific understanding, often ahead of guidelines
Not directly relevant to this paradigm
Metabolic Optimization
Proactive targets for optimal health, not just disease absence
Not directly relevant to this paradigm
Study Details
- Type
- research.studyTypes.observational
Related Biomarkers
Calculate & Evaluate on Metabolicum
Related Studies
Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
DiNicolantonio et al. • Open Heart • 2018
10-30% of populations have subclinical deficiency (<0.80 mmol/L); 48-50% US consumes below RDA; serum reflects <1% of body stores; linked to hypertension, arrhythmias, atherosclerosis, heart failure
Relation of hair graying to coronary artery disease
ElFaramawy et al. • Egyptian Heart Journal • 2018
Hair whitening independently predicts CAD: OR 1.31 (95% CI 1.09-1.57, p=0.004); patients with CAD had significantly higher HWS (60.1% vs 32.1%, p<0.001)
Saklayen 2018: Global Epidemic of Metabolic Syndrome
Saklayen • Current Hypertension Reports • 2018
Metabolic syndrome affects 25% of adults globally